6.
[1]. Rena Nishizawa, et al. Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite. Bioorg Med Chem Lett. 7 Feb 1;17():77-1.
[]. Vikas N Telvekar, et al. Novel -(-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives as anti-tubercular agents. Bioorg Med Chem Lett. 1 Jan 1;(1):649-5.
H-H15-H19-H5
P61-P64-P7-P71-P8-P+P5-P4+P4-P5+P51+P8-P-P6+P64-P4+P-P45-P51
GHS7